DKA Management Protocol: A Complete Step-by-Step for Fluids, Insulin, K+, and Dextrose

DKA is defined by the triad of hyperglycemia (typically >300 mg/dL), ketonemia or ketonuria (positive urine or serum ketones), and metabolic acidosis (pH <7.3, bicarbonate <15 mEq/L). The most common presentation is a known or newly diagnosed diabetic patient with acute deterioration: vomiting, anorexia, lethargy, dehydration, Kussmaul respiration (deep, rapid breathing to compensate for acidosis), and a sweet or acetone-like breath odor.

Common precipitating factors include: concurrent infection (UTI, pneumonia, pyometra — the most common trigger), pancreatitis, inappropriate insulin dosing or missed doses, corticosteroid administration, and any significant concurrent illness causing stress hormone elevation.

Fluid resuscitation is the first and most important intervention in DKA management. Most DKA patients are 7-12% dehydrated. Fluid therapy alone can reduce blood glucose by 50-75 mg/dL by improving renal perfusion and glucose excretion.

Initial fluid choice: 0.9% NaCl (normal saline) is the standard initial fluid. It provides volume expansion, promotes renal glucose and ketone clearance, and does not contain potassium (allowing controlled supplementation). Some clinicians prefer balanced crystalloids after initial resuscitation, but 0.9% NaCl remains the standard first-line choice.

Rate calculation: Correct dehydration deficit over 12-24 hours. For a 10 kg dog that is 8% dehydrated: deficit = 10 kg × 0.08 = 0.8 L = 800 mL. Add maintenance requirements (approximately 2-3 mL/kg/hr) and ongoing losses (vomiting, diarrhea). Avoid excessively rapid fluid administration, which can contribute to cerebral edema.

Insulin is essential for halting ketogenesis and allowing cellular glucose uptake. However, insulin must be started only after adequate fluid resuscitation has begun and potassium has been assessed.

Preparation (regular insulin CRI):

Dogs: Add 2.2 U/kg regular insulin to 250 mL 0.9% NaCl. Run 50 mL through the line first to saturate insulin binding sites on the tubing, then start at 10 mL/hr.

Cats: Add 1.1 U/kg regular insulin to 250 mL 0.9% NaCl. Run 50 mL through the line first, then start at 10 mL/hr.

Critical rule: Do NOT start insulin if potassium is below 3.5 mEq/L. Insulin drives potassium intracellularly; starting insulin in a hypokalemic patient can cause fatal hypokalemia and cardiac arrest. Supplement potassium first and recheck before initiating insulin.

DKA patients almost universally have total body potassium depletion, even if serum K+ is normal or elevated at presentation. The initial serum potassium may be artificially elevated due to acidosis (H+ shifts intracellularly, K+ shifts extracellularly), insulin deficiency, and dehydration-related hemoconcentration. As treatment corrects these factors, K+ plummets rapidly.

Use the Potassium Sliding Scale Calculator to determine supplementation rates. Recheck potassium every 2-4 hours during the initial treatment phase. Remember that insulin drives K+ intracellularly, so potassium requirements increase after insulin is started.

This is where many clinicians make critical errors. As blood glucose decreases with insulin therapy, dextrose must be added to the IV fluids. The key principle: do NOT stop insulin when glucose reaches target. Insulin is needed to resolve ketoacidosis; stopping insulin allows ketogenesis to resume even if glucose is controlled.

Protocol:

When BG drops below 250 mg/dL: Add 2.5% dextrose to IV fluids and reduce insulin CRI rate by 25-50%.

When BG drops below 150 mg/dL: Increase to 5% dextrose and further reduce insulin CRI rate.

When BG drops below 100 mg/dL: Increase to 5-7.5% dextrose; consider stopping insulin temporarily and re-bolusing dextrose if needed.

Target blood glucose during DKA treatment is 150-250 mg/dL. The goal is NOT to normalize glucose; it is to maintain moderate hyperglycemia while continuing insulin to resolve ketosis. Blood glucose should decline at approximately 50-75 mg/dL/hr, not faster.

DKA management requires intensive, structured monitoring to detect and respond to changes promptly.

Transition from insulin CRI to subcutaneous insulin when the patient is: eating voluntarily, well hydrated, blood glucose is 150-300 mg/dL on a stable low-rate CRI, ketones are resolving or negative, and electrolytes are stable. Administer the first dose of intermediate or long-acting insulin (NPH, glargine, or PZI) 1-2 hours before discontinuing the CRI to avoid a gap in insulin coverage. Typical starting doses: dogs 0.25-0.5 U/kg BID (NPH); cats 1-2 U/cat BID (glargine or PZI).